4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-129156
Options or other derivatives
- Chief Executive Officer acquired 750,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kirn David · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-25 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +750,000 | 750,000 | D |
Loading xslF345X06/ownership.xml…